The fourth and final session of our 2019 webinar series focuses on the economic and legal factors affecting biosimilar pricing and uptake.
NERA Economic Consulting experts David Blackburn, Ph.D. and Rasmus Jørgensen, Ph.D. provide their unique insights in the US and European biosimilar markets, including a discussion of key similarities and differences in pricing and market access in the two regions.
Willkie partner Heather M. Schneider and Taylor Wessing partner Matthew Royle discuss key legal aspects of biosimilar regulation that may be affecting pricing and market access.
This session also provides a brief update on key biosimilar decisions, legislation and events from 2019.
